Results from a phase 3 clinical trial show promise for a new standard of care for treating people with advanced cervical ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

A short course of chemotherapy given before conventional treatment significantly cuts the risk of dying from cervical cancer, ...

A new chemotherapy regimen significantly boosts survival rates in cervical cancer patients and reduces the risk of death by ...

In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of ...

More than 90% of cervical cancer cases are caused by human papillomavirus (HPV) infection. HPV is a common sexually ...

Called the Interlace trial, it was funded by Cancer Research UK and UCL Cancer Trials Centre. 500 women were given the choice ...

A new treatment regime for cervical cancer cuts the risk of death by 40%, according to a large-scale study. Researchers at ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows. The study ...

FIGO is delighted to officially join The Global HPV Consortium housed at the Sabin Vaccine Institute, a public and private ...

A new treatment plan for cervical cancer has shown a 40% reduction in the risk of death, offering hope for improved survival ...